Solensia 7 mg Solution is a Health Canada–registered veterinary drug (DIN 02518449) held by Zoetis Canada Inc, containing Frunevetmab. Health Canada lists its status as Marketed (status date 14 Apr 2022). Nexara Health has matched 4 registrations of Frunevetmab across 4 other regulated markets.
Health Canada registration
| DIN | 02518449 |
|---|---|
| Brand name | Solensia |
| Active ingredient | Frunevetmab |
| Strength | 7 mg |
| Dosage form | Solution |
| Route | Subcutaneous |
| Company | Zoetis Canada Inc |
| Status | Marketed — 14 Apr 2022 |
| Class | Veterinary |
| ATC | |
| AHFS | 10:00.00 |
| Regulator record | Health Canada DPD entry · Product monograph |
Frunevetmab registered in other markets
4 registrations of the same molecule in 4 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Denmark | Solensia | Zoetis Belgium SA | 7 mg/ml | injektionsvæske, opløsning | Central | Laegemiddelstyrelsen |
| European Union (EMA) | Solensia | — | Authorised | EMA centrally authorised | ||
| Iceland | Solensia | Icepharma - óskráð | 7 mg/ml | stl | 0 | Lyfjastofnun lyfjaverdskra |
| Poland | Solensia | Zoetis Belgium SA | 7 mg/ml | Roztwór do wstrzykiwań | URPL RPL |
See every manufacturer of Frunevetmab worldwide →
Regulator price references for Frunevetmab
Published list or reimbursement prices for Frunevetmab presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Iceland | Solensia | 7mg/1ml | hgl | 10,300.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Solensia (DIN 02518449) marketed in Canada?
Yes. Health Canada lists DIN 02518449 as Marketed as of 14 Apr 2022.
Who holds the Canadian licence for this product?
Zoetis Canada Inc is the company of record in the Health Canada Drug Product Database.
Is Frunevetmab registered outside Canada?
Yes — Nexara Health has matched 4 registrations in 4 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02518449, status date 2022-04-14; national medicine registries: EMA centrally authorised, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, URPL RPL; price sources: Lyfjastofnun lyfjaverdskra. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02518449, status date 2022-04-14; national medicine registries: EMA centrally authorised, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, URPL RPL; price sources: Lyfjastofnun lyfjaverdskra.
Health Canada Drug Product Database (DPD), DIN 02518449, status date 2022-04-14; national medicine registries: EMA centrally authorised, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, URPL RPL; price sources: Lyfjastofnun lyfjaverdskra. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.